0 Comment
Editorial Ciencia (EFE).- The first results of a clinical trial with 16 volunteers showed that an experimental and personalized messenger RNA vaccine induces a substantial immune response and potentially delays the relapse of patients in a form of pancreatic cancer, ductal adenocarcinoma pancreatic. It does this when used with other treatments, such as chemotherapy, surgery,... Read More